Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Study of SHR-A1904 in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma

NCT07520357 is registered in ClinicalTrials.gov with Beijing GoBroad Hospital as lead sponsor.

NCT NCT07520357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07520357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Study of SHR-A1904 in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma
Lead sponsor
Beijing GoBroad Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
February 28, 2029
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced neuroendocrine carcinoma